Melanin Building Block as Scaffold for Dynamic Submicromolar Galectin Inhibitors

Galectins, β-galactoside-binding soluble proteins, are involved in a multitude of biological functions and several diseases, so numerous galectin inhibitors, from small molecules to multivalent glycoconjugates, have been developed and investigated as tools for therapeutic applications. Notably, multivalent ligands on a biocompatible backbone offer a promising perspective for creating high-performance selective inhibitors with nanomolar affinity. Leveraging the oxidative polymerization of 5,6-dihydroxyindole (DHI), a key intermediate of eumelanin pigments, here, we present the synthesis and complete nuclear magnetic resonance characterization of a submicromolar multivalent ligand of galectin-3 based on a naturally biocompatible eumelanin backbone. The integration of several complementary techniques, namely, UV–vis spectrometry, dynamic light scattering, isothermal titration calorimetry, and biolayer interferometry, in the investigation of galectin-3–eumelanin-related ligand interactions, allowed us to calculate the KD and to propose a model for the protein–polymer interaction.

Authors

Institutions

Publication Details

Journal
ACS Omega
Published
2026-03-22
DOI
https://doi.org/10.1021/acsomega.5c08192
Primary Topic
Galectins and Cancer Biology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Melanin Building Block as Scaffold for Dynamic Submicromolar Galectin Inhibitors

Domenica Capasso, Alfonso Iadonisi, Alessandro Pezzella, Rita Russo et al.
ACS Omega
Galectins and Cancer Biology
article

Melanin Building Block as Scaffold for Dynamic Submicromolar Galectin Inhibitors

Domenica Capasso, Alfonso Iadonisi, Alessandro Pezzella, Rita Russo, Emilia Maria Pedone, Luciano Pirone, Martina Filocaso, S. Di Gaetano, Emanuele Carrella
article en

Abstract

Galectins, β-galactoside-binding soluble proteins, are involved in a multitude of biological functions and several diseases, so numerous galectin inhibitors, from small molecules to multivalent glycoconjugates, have been developed and investigated as tools for therapeutic applications. Notably, multivalent ligands on a biocompatible backbone offer a promising perspective for creating high-performance selective inhibitors with nanomolar affinity. Leveraging the oxidative polymerization of 5,6-dihydroxyindole (DHI), a key intermediate of eumelanin pigments, here, we present the synthesis and complete nuclear magnetic resonance characterization of a submicromolar multivalent ligand of galectin-3 based on a naturally biocompatible eumelanin backbone. The integration of several complementary techniques, namely, UV–vis spectrometry, dynamic light scattering, isothermal titration calorimetry, and biolayer interferometry, in the investigation of galectin-3–eumelanin-related ligand interactions, allowed us to calculate the KD and to propose a model for the protein–polymer interaction.

ACS Omega
University of Campania "Luigi Vanvitelli" (IT), Federico II University Hospital (IT), Institute of Biostructure and Bioimaging (IT), National Research Council (IT), National Interuniversity Consortium of Materials Science and Technology (IT), Institute of Polymers, Composites and Biomaterials (IT), BioElectronics (United States) (US), Institute of Crystallography (IT), University of Naples Federico II (IT)
Openalex Percentile: Top 12%
Galectins and Cancer Biology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.